ProKidney(PROK) - 2024 Q1 - Quarterly Results

Exhibit 99.1 ProKidney Reports Business Updates and First Quarter 2024 Financial Results Clinical Updates • Final results from RMCL-002 Phase 2 trial to be presented in the Late Breaking Clinical Trials session at the European Renal Association (ERA) Congress on May 25, 2024. An investor call to provide a perspective on CKD with Dr. Arnold Silva and Dr. Steven Coca and a recap of the RMCL-002 data is planned for May 28, 2024 • On schedule to resume manufacturing and PROACT 1 Phase 3 trial, commence PROACT 2 ...